Open Access

Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta‑analysis

  • Authors:
    • Yiting You
    • Yadong Li
    • Yiting Xiao
    • Jinsong Zhang
  • View Affiliations

  • Published online on: June 10, 2021     https://doi.org/10.3892/mco.2021.2318
  • Article Number: 156
  • Copyright: © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Infantile hemangioma (IH) is a common disease, and drug therapy is the most common treatment method. Clinically, steroids have long been used as first‑line drugs, but in recent years, some doctors have begun to use propranolol to treat infantile hemangiomas (IHs). The present study performed a meta‑analysis to evaluate the clinical effects of propranolol in comparison with steroids in the treatment of infantile hemangiomas. A detailed review of the literature on PubMed, Cochrane Library, Embase and Web of Science was performed prior to March 31, 2020. All literatures were compared with the clinical effects of propranolol and steroids in the treatment of infantile hemangiomas. A total of two researchers independently screened the literature according to the selection criteria, extracted data and assessed the risk of bias for the included studies. Review Manager 5.3 was used to meta‑analyze all the included studies. According to the selection criteria, nine articles were included in the present study. The meta‑analysis revealed that the effective rate of propranolol was greater than that of steroids in treating infantile hemangiomas [odds ratio (OR), 3.96, 95% confidence interval (CI), 2.47‑6.37; P<0.00001]. Additionally, propranolol had fewer complications than steroids (OR, 0.21; 95% CI, 0.12‑0.36; P<0.00001). The recurrence rate of the two groups was not statistically different (OR, 1.83; 95% CI, 0.59‑5.70; P=0.3) and the surgical resection rate of propranolol was lower than steroids (OR, 0.19; 95% CI, 0.08‑0.46; P=0.0002). The present study demonstrated that propranolol is more effective than steroids for the treatment of IHs, and provides a theoretical basis for the clinical use of propranolol as an alternative to steroids.

Related Articles

Journal Cover

August-2021
Volume 15 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
You Y, Li Y, Xiao Y and Zhang J: Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta‑analysis. Mol Clin Oncol 15: 156, 2021
APA
You, Y., Li, Y., Xiao, Y., & Zhang, J. (2021). Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta‑analysis. Molecular and Clinical Oncology, 15, 156. https://doi.org/10.3892/mco.2021.2318
MLA
You, Y., Li, Y., Xiao, Y., Zhang, J."Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta‑analysis". Molecular and Clinical Oncology 15.2 (2021): 156.
Chicago
You, Y., Li, Y., Xiao, Y., Zhang, J."Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta‑analysis". Molecular and Clinical Oncology 15, no. 2 (2021): 156. https://doi.org/10.3892/mco.2021.2318